Related Experiment Video
Updated: Jun 22, 2026

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature
Published on: April 1, 2014
Postinfectious purpura fulminans: A case report
Romina F Pombar1, Romina L Tellería1, Belén Bianco2
1Department of Dermatology; Hospital de Pediatría S.A.M.I.C. Prof. Dr. Juan P. Garrahan, City of Buenos Aires, Argentina.
Acquired postinfectious purpura fulminans, a rare condition, involves skin necrosis and disseminated intravascular coagulation (DIC) after infection. This case highlights transient protein S deficiency as a key factor in pediatric patients.
Area of Science:
- Hematology
- Pediatric Medicine
- Dermatology
Background:
- Acquired postinfectious purpura fulminans is a rare, severe condition presenting with skin necrosis and disseminated intravascular coagulation (DIC).
- It predominantly affects children, often following an infectious episode, and is linked to transient autoantibody-mediated protein S deficiency.
- The underlying mechanism involves a temporary deficiency in protein S, leading to a hypercoagulable state.
Observation:
- A previously healthy 8-year-old boy presented with purpuric skin lesions characteristic of purpura fulminans.
- The patient exhibited signs of DIC without evidence of active sepsis.
- Diagnostic evaluation confirmed a transient plasma protein S deficiency.
Findings:
- The case demonstrates a clear association between purpura fulminans, DIC, and transient protein S deficiency in a pediatric patient.
- Treatment involved fresh frozen plasma replacement and anticoagulation therapy.
- Protein S activity remained diminished for two months post-event.
Implications:
- This case underscores the importance of recognizing transient protein S deficiency in the pathophysiology of acquired postinfectious purpura fulminans.
- Early diagnosis and appropriate management, including plasma replacement and anticoagulation, are crucial for favorable outcomes in affected children.
- Further research into the immunologic mechanisms of transient protein S deficiency may reveal novel therapeutic targets.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Acute Pyelonephritis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Rocky Mountain Spotted Fever
Peptic Ulcer
Brain Abscess l: Introduction

